0001415889-16-005478.txt : 20160411 0001415889-16-005478.hdr.sgml : 20160411 20160411164011 ACCESSION NUMBER: 0001415889-16-005478 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160411 DATE AS OF CHANGE: 20160411 EFFECTIVENESS DATE: 20160411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261048 FILM NUMBER: 161565504 BUSINESS ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 BUSINESS PHONE: 917-842-2353 MAIL ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 D 1 primary_doc.xml X0707 D LIVE 0001604191 AzurRx BioPharma, Inc. 760 Parkside Avenue Downstate Biotech. Incubator Suite 217 Brooklyn NY NEW YORK 11226 646-699-7855 DELAWARE None BioPharma d'Azur, Inc. Corporation true 2014 Johan (Thijs) Spoor c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 217 Brooklyn NY NEW YORK 11226 Executive Officer Director Edward Borkowski c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 217 Brooklyn NY NEW YORK 11226 Director Alastair Riddell c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 217 Brooklyn NY NEW YORK 11226 Director Maged Shenouda c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 217 Brooklyn NY NEW YORK 11226 Director Biotechnology Decline to Disclose 06b false 2016-03-30 false true true true false 0 Alexander Capital, LP 40077 None None 17 State Street 5Th Floor New York NY NEW YORK 10004 FL FLORIDA MD MARYLAND NY NEW YORK 12000000 635000 11365000 false 0 4 57150 0 60000 true Proceeds will be used for payroll and expense reimbursements. AzurRx BioPharma, Inc. /s/ Johan M. (Thijs) Spoor Johan M. (Thijs) Spoor President and CEO 2016-04-11